Design Optimization
PK sparse sampling scheme optimization for phase III clinical trial in Oncology
PK sparse sampling scheme optimization for phase III clinical trial in Oncology
Designing and searching effective drug molecules for various diseases
Calculate acidity and basicity of small drug molecules
In silico Quantitative Structure-Toxicity Relationship (QSTR) Model for Predicting Toxicity of Aromatic Aldehydes using Extended Topochemical Atom (ETA) Indices.
Coupled computational and structure-guided approaches for Identifying Inhibitors of Escherichia coli target (AcrA and AcrB fusion proteins).
Coupled computational and structure-guided approaches for identifying NCEs inhibitors.
In silico SD Bioequivalence trial to replace clinical trial
Design from Scratch an Influenza Vaccine
In Silico trial to replace Bioequivalence trial for non-proportional formulation
In Silico trial to establish a IVIVR model based on Bioequivalence outcome